Guo X, Chen G
Conclusion: Cinchonine, a potential oral small-molecule GLP-1R agonist, could reduce blood glucose and ameliorate NASH, providing a strategy for developing small-molecule GLP-1R agonists
[DOI] [PubMed] [Google Scholar] 32.Parr MK, Botr F, Na A, Hengevoss J, Diel P, Wolber G
This oral GLP-1 pill can be a helpful alternative to those who are looking to take a GLP-1 to aid in weight loss, but do not like needles
McKee, N
Figure 10 In addition to the sulfonamides, e.g., 40 and 41 , the spiro-oxindole dihydroquinazolinone derivative 42 was identified in the screening campaign and subsequently a large series of related analogues were made, e.g., by applying rapid MW-assisted reactions and thereafter examined as IRAP inhibitors in bioassays (Engen et al., 2020) (Figure 10)